the combined diagnostic value of hemostasis and cell injury markers in sepsis-associated disseminated intravascular coagulation: a multi-center prospective observational study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044411

Enrollment

Unknown

Registered

2021-03-18

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis associated DIC

Interventions

sepsis:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 Patients greater than or equal to 18 years old; 2 Patients who meet the sepsis 3.0 standard proposed by the international consensus of sepsis experts in 2016.

Exclusion criteria

Exclusion criteria: 1. Heparin induced thrombocytopenia; 2. thrombotic thrombocytopenic purpura; 3. antiphospholipid syndrome; 4. trauma; 5. pregnancy; 6. toxicosis; 7. liver cirrhosis classified as Child-Pugh grade C ; 8. thrombophilia (AT deficiency,Protein C deficiency,Protein S deficiency); 9. patients with a current treatment that interfered with coagulation (warfarin, dabigatran, rivaroxaban, heparin/low molecular weight heparin).

Design outcomes

Primary

Measure	Time frame
DIC score;	—

Secondary

Measure	Time frame
mortality for 28 days;	—

Countries

China

Contacts

Public ContactTongchaoyang

Zhongshan Hospital Fudan University

tong.chaoyang@zs-hospital.sh.cn+86 13681970935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026